Data / Form D filings / Nora Therapeutics, Inc.
Nora Therapeutics, Inc.: Form D filings
Nora Therapeutics, Inc., a biotechnology company in Palo Alto, CA, filed 6 Form D notices with the SEC between 2009 and 2015. The latest, on October 13, 2015, reports $1 million sold of a $3 million offering to 6 investors.
Find out what Nora Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 530 LYTTON AVENUE, 2ND FLOOR, Palo Alto, CA, 94301
- Phone
- 1-650-479-5331
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1461695
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 13, 2015 | New notice | $3,000,000 | $1,000,000 | $2,000,000 | 6 | Sep 29, 2015 | sec.gov |
| May 14, 2015 | New notice | $536,709 | $0 | $536,709 | 1 | Yet to occur | sec.gov |
| Apr 23, 2014 | New notice | $18,000,000 | $18,000,000 | $0 | 6 | Apr 11, 2014 | sec.gov |
| Sep 23, 2010 | New notice | $32,554,999 | $14,880,000 | $17,674,999 | 5 | Sep 8, 2010 | sec.gov |
| Jun 2, 2010 | Amendment | $25,137,000 | $2,932,000 | $22,205,000 | 4 | Mar 31, 2009 | sec.gov |
| Apr 13, 2009 | New notice | $24,000,000 | $1,000,000 | $23,000,000 | 4 | Mar 31, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joseph L. Turner, Jr. | Director | |
| Chen K. Yu | Director | |
| David K. Schnell | Director | |
| Dennis K. Fenton | Director | |
| Donald K. Hayden, Jr. | Director | |
| Martin K. Vogelbaum | Director | |
| Jeffrey K. Tong | Executive Officer, Director | |
| Anupam K. Dalal | Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
- Tempest Therapeutics, Inc. $7.5 million · Oct 14, 2026
- Lionheart Health, Inc. $387,500 · Oct 7, 2026
- Rakuten Medical, Inc. $9 million · Oct 6, 2026
- Zonaliz, Inc. $2.5 million · Oct 5, 2026
- Altay Therapeutics, Inc. $15.7 million · Oct 2, 2026
- Sialia Therapeutics, Inc. $1.5 million · Sep 29, 2026
- Vetmab Biosciences, Inc. $11.4 million · Sep 29, 2026
Every Form D from the week of Oct 12, 2015 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Nora Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.